Last update 21 Nov 2024

Pt(0506)101

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
BAX x Bcl-2
Mechanism
BAX agonists(Apoptosis regulator BAX agonists), Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Advanced Malignant Solid NeoplasmGastroesophageal junction adenocarcinomastomach adenocarcinoma
Inactive Indication-
Originator Organization
Beijing Fengshuo Weikang Technology Development Co LtdBeijing Fengshuo Weikang Technology Development Co Ltd
Active Organization
Beijing Showby Pharmaceutical Co LtdBeijing Showby Pharmaceutical Co LtdBeijing Fengshuo Weikang Technology Development Co LtdBeijing Fengshuo Weikang Technology Development Co Ltd
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationSpecial Review Project (CN)
Login to view timeline

Related

1
Clinical Trials associated with Pt(0506)101
CTR20181935 / CompletedPhase 1
评价注射用Pt(0506)101治疗晚期恶性实体肿瘤的安全性、耐受性和药代动力学的开放、剂量递增Ia期临床研究
[Translation] An open-label, dose-escalation phase Ia clinical study to evaluate the safety, tolerability, and pharmacokinetics of Pt(0506)101 for injection in the treatment of advanced malignant solid tumors
100 Clinical Results associated with Pt(0506)101
Login to view more data
100 Translational Medicine associated with Pt(0506)101
Login to view more data
100 Patents (Medical) associated with Pt(0506)101
Login to view more data
100 Deals associated with Pt(0506)101
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
CN
Beijing Fengshuo Weikang Technology Development Co LtdBeijing Fengshuo Weikang Technology Development Co Ltd
23 Oct 2018
Gastroesophageal junction adenocarcinomaIND Approval
CN
Beijing Showby Pharmaceutical Co LtdBeijing Showby Pharmaceutical Co Ltd
18 Sep 2024
stomach adenocarcinomaIND Approval
CN
Beijing Showby Pharmaceutical Co LtdBeijing Showby Pharmaceutical Co Ltd
18 Sep 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free